42 related articles for article (PubMed ID: 9209653)
1. The positive nuclear staining observed with monoclonal antibody against PRAD1/cyclin D1 correlates with mRNA expression in mantle cell lymphoma.
Kuroda H; Komatsu H; Nakamura S; Niitsu Y; Takahashi T; Ueda R; Seto M
Jpn J Cancer Res; 1995 Sep; 86(9):890-8. PubMed ID: 7591969
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Applications of Pretargeting.
Verhoeven M; Seimbille Y; Dalm SU
Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31480515
[TBL] [Abstract][Full Text] [Related]
3. CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.
Bonelli P; Tuccillo FM; Borrelli A; Schiattarella A; Buonaguro FM
Biomed Res Int; 2014; 2014():361020. PubMed ID: 24605326
[TBL] [Abstract][Full Text] [Related]
4. miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model.
Sandhu SK; Volinia S; Costinean S; Galasso M; Neinast R; Santhanam R; Parthun MR; Perrotti D; Marcucci G; Garzon R; Croce CM
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20047-52. PubMed ID: 23169640
[TBL] [Abstract][Full Text] [Related]
5. P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines.
Shirsath NP; Manohar SM; Joshi KS
Mol Cancer; 2012 Oct; 11():77. PubMed ID: 23075291
[TBL] [Abstract][Full Text] [Related]
6. Primary gastric mantle cell lymphoma.
Petranovic D; Pilcic G; Peitl M; Cubranic A; Valkovic T; Nacinovic AD; Lucin K; Jonjic N
Hematol Rep; 2012 Jan; 4(1):e1. PubMed ID: 22567215
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.
Michalides RJ
J Clin Pathol; 1999 Aug; 52(8):555-68. PubMed ID: 10645224
[No Abstract] [Full Text] [Related]
8. Cyclin D1 overexpression in malignant lymphomas.
Nakamura S; Yatabe Y; Seto M
Pathol Int; 1997 Jul; 47(7):421-9. PubMed ID: 9234379
[TBL] [Abstract][Full Text] [Related]
9. PRAD1/Cyclin D1 gene overexpression in mantle cell lymphoma.
Oka K; Ohno T; Yamaguchi M; Mahmud N; Miwa H; Kita K; Shiku H; Shirakawa S
Leuk Lymphoma; 1996 Mar; 21(1-2):37-42. PubMed ID: 8907267
[TBL] [Abstract][Full Text] [Related]
10. Bcl-1/cyclin D1 in malignant lymphoma.
de Boer CJ; van Krieken JH; Schuuring E; Kluin PM
Ann Oncol; 1997; 8 Suppl 2():109-17. PubMed ID: 9209653
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
13. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
14. Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma.
Nakamura S; Yatabe Y; Kuroda H; Ueda R; Takahashi T; Suchi T; Seto M
Leukemia; 1997 Apr; 11 Suppl 3():536-7. PubMed ID: 9209449
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
